Alignment Healthcare Debt to Equity Ratio 2020-2025 | ALHC

Current and historical debt to equity ratio values for Alignment Healthcare (ALHC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Alignment Healthcare debt/equity for the three months ending June 30, 2025 was 2.29.
Alignment Healthcare Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-06-30 $0.86B $0.14B 6.10
2025-03-31 $0.79B $0.11B 7.22
2024-12-31 $0.68B $0.10B 6.75
2024-09-30 $0.58B $0.12B 4.99
2024-06-30 $0.59B $0.13B 4.74
2024-03-31 $0.50B $0.13B 3.80
2023-12-31 $0.43B $0.16B 2.74
2023-09-30 $0.58B $0.19B 3.07
2023-06-30 $0.57B $0.21B 2.71
2023-03-31 $0.54B $0.22B 2.40
2022-12-31 $0.40B $0.24B 1.65
2022-09-30 $0.51B $0.27B 1.86
2022-06-30 $0.37B $0.29B 1.27
2022-03-31 $0.35B $0.29B 1.21
2021-12-31 $0.33B $0.31B 1.06
2021-09-30 $0.33B $0.33B 1.02
2021-06-30 $0.33B $0.34B 0.97
2021-03-31 $0.33B $0.35B 0.92
2020-12-31 $0.31B $0.03B 10.06
2020-09-30 $0.00B $0.00B 0.00
2020-06-30 $0.00B $0.00B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.27B $-0.08B -3.46
Sector Industry Market Cap Revenue
Medical Medical Services $3.240B $2.704B
Alignment Healthcare Inc. is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $92.778B 11.54
Cencora (COR) United States $56.537B 18.83
Charles River Laboratories (CRL) United States $8.037B 15.25
Amplifon S.p.A (AMFPF) Italy $3.937B 21.82
Concentras Parent (CON) United States $3.050B 19.35
AMN Healthcare Services Inc (AMN) United States $0.796B 9.85
Agilon Health (AGL) United States $0.530B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.424B 0.00
Ascend Wellness Holdings (AAWH) United States $0.173B 0.00
Co-Diagnostics (CODX) United States $0.013B 0.00
Aclarion (ACON) United States $0.004B 0.00